Schrödinger

Schrödinger, Inc. is a New York-based scientific software and biotechnology company founded in 1990. It specializes in physics-based computational platforms that enhance drug discovery and materials science applications. The company operates in two main segments: Software, which offers tools for molecular discovery, and Drug Discovery, which develops preclinical and clinical programs both internally and through collaborations. Schrödinger's software simulates molecular behavior at the atomic level, facilitating faster and more cost-effective discovery of therapeutics and materials. Key products include Glide for virtual screening, Prime for protein structure prediction, and FEP+ for binding affinity prediction. The company also provides custom enterprise software, training, and research-based drug discovery projects. With over 30 years of research and development, Schrödinger has established partnerships with leading biotech and pharmaceutical companies, contributing to advancements in drug candidates and materials.

Partnerships

 

  

  

 

  

  

 

  

  

Clients